Novartis (United States)

7.0k papers and 297.1k indexed citations i.

About

In recent decades, authors affiliated with Novartis (United States) have published 7.0k papers, which have received a total of 297.1k indexed citations. Scholars at this organization have produced 1.7k papers in Molecular Biology, 1.3k papers in Oncology and 1.1k papers in Pulmonary and Respiratory Medicine on the topics of Chronic Myeloid Leukemia Treatments (354 papers), Chronic Lymphocytic Leukemia Research (345 papers) and Advanced Breast Cancer Therapies (258 papers). Their work is cited by papers focused on Molecular Biology (93.4k citations), Oncology (53.7k citations) and Pulmonary and Respiratory Medicine (39.4k citations). Authors at Novartis (United States) collaborate with scholars in United States, Switzerland and United Kingdom and have published in prestigious journals including Nature, Science and Cell. Some of Novartis (United States)'s most productive authors include Scott D. Solomon, John J.V. McMurray, Michael R. Zile, Peter Atadja and Victor Shi.

In The Last Decade

Fields of papers published by authors at Novartis (United States)

Since Specialization
EngineeringComputer SciencePhysics and AstronomyMathematicsEarth and Planetary SciencesEnergyEnvironmental ScienceMaterials ScienceChemical EngineeringChemistryAgricultural and Biological SciencesVeterinaryDecision SciencesArts and HumanitiesBusiness, Management and AccountingSocial SciencesPsychologyEconomics, Econometrics and FinanceHealth ProfessionsDentistryMedicineBiochemistry, Genetics and Molecular BiologyNeuroscienceNursingImmunology and MicrobiologyPharmacology, Toxicology and Pharmaceutics

This network shows the specialization of papers affiliated with Novartis (United States) at the time of their publication. Nodes represent fields, and links connect fields that are likely to share authors.

Countries citing scholars working at Novartis (United States)

Since Specialization
Citations

This map shows the geographic impact of research produced by authors working at Novartis (United States). It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Novartis (United States) with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Novartis (United States) more than expected).

Rankless by CCL
2025